Zhaojia Gao

P.R. China
Changzhou, 213003, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

METTL5 reprograms glycolytic metabolism and promotes non-small cell lung cancer progression by modifying PGAM1.

METTL5 reprograms glycolytic metabolism and promotes non-small cell lung cancer progression by modifying PGAM1.

Journal: Oncology letters

Published: September 19, 2025

Leucine-rich repeat-containing G protein-coupled receptor 4 promotes proliferation, invasion and migration, and inhibits apoptosis in non-small cell lung cancer cells.

Leucine-rich repeat-containing G protein-coupled receptor 4 promotes proliferation, invasion and migration, and inhibits apoptosis in non-small cell lung cancer cells.

Journal: Oncology letters

Published: April 10, 2025

Integration of multiple machine learning approaches develops a gene mutation-based classifier for accurate immunotherapy outcomes.

Integration of multiple machine learning approaches develops a gene mutation-based classifier for accurate immunotherapy outcomes.

Journal: NPJ precision oncology

Published: July 11, 2024

CDCA gene family promotes progression and prognosis in lung adenocarcinoma.

CDCA gene family promotes progression and prognosis in lung adenocarcinoma.

Journal: Medicine

Published: June 14, 2024

VIRMA promotes NSCLC progression by modifying ADAR m6A and increasing the activity of the TGF-β signaling pathway.

VIRMA promotes NSCLC progression by modifying ADAR m6A and increasing the activity of the TGF-β signaling pathway.

Journal: Scientific reports

Published: May 24, 2024

MDFI is a novel biomarker for poor prognosis in LUAD.

MDFI is a novel biomarker for poor prognosis in LUAD.

Journal: Frontiers in oncology

Published: July 28, 2022

Role of WTAP in Cancer: From Mechanisms to the Therapeutic Potential.

Role of WTAP in Cancer: From Mechanisms to the Therapeutic Potential.

Journal: Biomolecules

Published: June 30, 2022

Corrigendum: Long Non-Coding RNA AL513318.2 as ceRNA Binding to hsa-miR-26a-5p Upregulates SLC6A8 Expression and Predicts Poor Prognosis in Non-Small Lung Cancer.

Corrigendum: Long Non-Coding RNA AL513318.2 as ceRNA Binding to hsa-miR-26a-5p Upregulates SLC6A8 Expression and Predicts Poor Prognosis in Non-Small Lung Cancer.

Journal: Frontiers in oncology

Published: February 18, 2022

Complete Video-Assisted Thoracoscopic Surgery and Traditional Open Surgery for Elderly Patients With NSCLC.

Complete Video-Assisted Thoracoscopic Surgery and Traditional Open Surgery for Elderly Patients With NSCLC.

Journal: Frontiers in surgery

Published: January 27, 2022

SLC6A8 is a Potential Biomarker for Poor Prognosis in Lung Adenocarcinoma.

SLC6A8 is a Potential Biomarker for Poor Prognosis in Lung Adenocarcinoma.

Journal: Frontiers in genetics

Published: December 29, 2021

Correlation of SIDT1 with Poor Prognosis and Immune Infiltration in Patients with Non-Small Cell Lung Cancer.

Correlation of SIDT1 with Poor Prognosis and Immune Infiltration in Patients with Non-Small Cell Lung Cancer.

Journal: International journal of general medicine

Published: November 12, 2021

Long Non-Coding RNA AL513318.2 as ceRNA Binding to hsa-miR-26a-5p Upregulates SLC6A8 Expression and Predicts Poor Prognosis in Non-Small Lung Cancer.

Long Non-Coding RNA AL513318.2 as ceRNA Binding to hsa-miR-26a-5p Upregulates SLC6A8 Expression and Predicts Poor Prognosis in Non-Small Lung Cancer.

Journal: Frontiers in oncology

Published: September 23, 2021

Showing 1-12 of 20

Last Updated: 09/26/2026